Molecular characteristics therapy in AML.
Radich
Gerald P
GP
D000208:Acute Disease; D000328:Adult; D000367:Age Factors; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology / Q000627:therapeutic use*; D002869:Chromosome Aberrations; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D016503:Drug Delivery Systems; D019008:Drug Resistance, Neoplasm; D015507:Drugs, Investigational / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007951:Leukemia, Myeloid / Q000145:classification / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000601:surgery; D015337:Multicenter Studies as Topic; D009154:Mutation; D009363:Neoplasm Proteins / Q000235:genetics*; D012307:Risk Factors; D016879:Salvage Therapy; D016019:Survival Analysis; D016896:Treatment Outcome
D015507:Drugs, Investigational; D009363:Neoplasm Proteins